Epstein JI - Search Results

1

Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. II. Standardization of methodology for histologic sections.

Mohler JL, Partin AW, Epstein JI, Lohr WD, Coffey DS. Mohler JL, et al. Among authors: epstein ji. J Urol. 1988 May;139(5):1085-90. doi: 10.1016/s0022-5347(17)42792-3. J Urol. 1988. PMID: 3283380

2

The use of nuclear morphometry to predict response to therapy in Wilms' tumor.

Gearhart JP, Partin AW, Leventhal B, Beckwith JB, Epstein JI. Gearhart JP, et al. Among authors: epstein ji. Cancer. 1992 Feb 1;69(3):804-8. doi: 10.1002/1097-0142(19920201)69:3<804::aid-cncr2820690332>3.0.co;2-7. Cancer. 1992. PMID: 1309682

3

Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography.

Rahmouni A, Yang A, Tempany CM, Frenkel T, Epstein J, Walsh P, Leichner PK, Ricci C, Zerhouni E. Rahmouni A, et al. J Comput Assist Tomogr. 1992 Nov-Dec;16(6):935-40. doi: 10.1097/00004728-199211000-00020. J Comput Assist Tomogr. 1992. PMID: 1385499

4

The biology of prostate cancer: new and future directions in predicting tumor behavior.

Partin AW, Carter HB, Epstein JI, Coffey DS. Partin AW, et al. Among authors: epstein ji. Monogr Pathol. 1992;(34):198-218. Monogr Pathol. 1992. PMID: 1406742 Review.

5

A quantitative histological analysis of the dilated ureter of childhood.

Lee BR, Partin AW, Epstein JI, Quinlan DM, Gosling JA, Gearhart JP. Lee BR, et al. Among authors: epstein ji. J Urol. 1992 Nov;148(5):1482-6. doi: 10.1016/s0022-5347(17)36944-6. J Urol. 1992. PMID: 1433552 Free article.

6

Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer.

Partin AW, Steinberg GD, Pitcock RV, Wu L, Piantadosi S, Coffey DS, Epstein JI. Partin AW, et al. Among authors: epstein ji. Cancer. 1992 Jul 1;70(1):161-8. doi: 10.1002/1097-0142(19920701)70:1<161::aid-cncr2820700126>3.0.co;2-5. Cancer. 1992. PMID: 1606538

7

Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy.

Epstein JI, Pizov G, Steinberg GD, Carter HB, Pitcock R, Armas OA, Partin A, Walsh PC. Epstein JI, et al. J Urol. 1992 Jul;148(1):87-91. doi: 10.1016/s0022-5347(17)36518-7. J Urol. 1992. PMID: 1613888 Free article. Review.

8

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.

Partin AW, Carter HB, Chan DW, Epstein JI, Oesterling JE, Rock RC, Weber JP, Walsh PC. Partin AW, et al. Among authors: epstein ji. J Urol. 1990 Apr;143(4):747-52. doi: 10.1016/s0022-5347(17)40079-6. J Urol. 1990. PMID: 1690309 Free article.

9

The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer.

Carter HB, Partin AW, Epstein JI, Chan DW, Walsh PC. Carter HB, et al. Among authors: epstein ji. J Urol. 1990 Nov;144(5):1167-70; discussion 1170-1. doi: 10.1016/s0022-5347(17)39683-0. J Urol. 1990. PMID: 1700143

10

Management of stage D1 adenocarcinoma of the prostate: the Johns Hopkins experience 1974 to 1987.

Steinberg GD, Epstein JI, Piantadosi S, Walsh PC. Steinberg GD, et al. Among authors: epstein ji. J Urol. 1990 Dec;144(6):1425-32. doi: 10.1016/s0022-5347(17)39759-8. J Urol. 1990. PMID: 1700157 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,064 results

Search Page

Filters